Travere Therapeutics Inc. (TVTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Travere Therapeutics Inc.

    NASDAQ: TVTX · Real-Time Price · USD
    21.64
    0.49 (2.32%)
    At close: Sep 05, 2025, 3:59 PM
    21.26
    -1.76%
    After-hours: Sep 05, 2025, 06:49 PM EDT

    Travere Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 233.18M 145.24M 212.02M 227.49M
    Cost of Revenue
    		 7.74M 11.45M 7.59M 6.78M
    Gross Profit
    		 225.43M 133.79M 204.43M 220.71M
    Operating Income
    		 -320.63M -376.74M -251.56M -139.5M
    Interest Income
    		 17.82M 21.77M 6.28M 1.99M
    Pretax Income
    		 -320.51M -376.11M -278.17M -179.68M
    Net Income
    		 -321.55M -111.4M -278.48M -180.09M
    Selling & General & Admin
    		 264.12M 265.54M 220.21M 149.88M
    Research & Development
    		 217.5M 244.99M 235.78M 210.33M
    Other Expenses
    		 75.39M n/a 974K 231K
    Operating Expenses
    		 557M 521.93M 455.99M 360.21M
    Interest Expense
    		 11.18M 11.33M 11.01M 19.68M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 557M 521.98M 463.58M 367M
    Income Tax Expense
    		 120K 223K 313K 409K
    Shares Outstanding (Basic)
    		 78.89M 74.27M 63.76M 59.83M
    Shares Outstanding (Diluted)
    		 78.89M 74.27M 63.76M 59.83M
    EPS (Basic)
    		 -4.08 -1.5 -4.37 -3.01
    EPS (Diluted)
    		 -4.08 -1.5 -4.37 -3.01
    EBITDA
    		 -265.77M -326.25M -299.42M -186.68M
    EBIT
    		 -309.33M -364.78M -320.14M -197.2M
    Depreciation & Amortization
    		 43.55M 38.53M 20.72M 26.62M

    Add to Watchlist